These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 30232521)
21. The Voltage-Gated Hv1 H Cozzolino M; Gyöngyösi A; Korpos E; Gogolak P; Naseem MU; Kállai J; Lanyi A; Panyi G Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047188 [TBL] [Abstract][Full Text] [Related]
22. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells. Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469 [TBL] [Abstract][Full Text] [Related]
23. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets. Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893 [No Abstract] [Full Text] [Related]
24. Differential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosis. Höchst B; Mikulec J; Baccega T; Metzger C; Welz M; Peusquens J; Tacke F; Knolle P; Kurts C; Diehl L; Ludwig-Portugall I PLoS One; 2015; 10(3):e0119662. PubMed ID: 25738302 [TBL] [Abstract][Full Text] [Related]
25. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment. Ostrand-Rosenberg S; Fenselau C J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384 [TBL] [Abstract][Full Text] [Related]
26. CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4/80- cells and promotes tumor progression. Matsui A; Yokoo H; Negishi Y; Endo-Takahashi Y; Chun NA; Kadouchi I; Suzuki R; Maruyama K; Aramaki Y; Semba K; Kobayashi E; Takahashi M; Murakami T PLoS One; 2012; 7(8):e44080. PubMed ID: 22952881 [TBL] [Abstract][Full Text] [Related]
27. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs. Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209 [TBL] [Abstract][Full Text] [Related]
28. CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice. Zoglmeier C; Bauer H; Noerenberg D; Wedekind G; Bittner P; Sandholzer N; Rapp M; Anz D; Endres S; Bourquin C Clin Cancer Res; 2011 Apr; 17(7):1765-75. PubMed ID: 21233400 [TBL] [Abstract][Full Text] [Related]
30. CD11b+ Ly6Chi Ly6G- immature myeloid cells recruited in response to Salmonella enterica serovar Typhimurium infection exhibit protective and immunosuppressive properties. Tam JW; Kullas AL; Mena P; Bliska JB; van der Velden AW Infect Immun; 2014 Jun; 82(6):2606-14. PubMed ID: 24711563 [TBL] [Abstract][Full Text] [Related]
31. Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects. Uehara T; Eikawa S; Nishida M; Kunisada Y; Yoshida A; Fujiwara T; Kunisada T; Ozaki T; Udono H Int Immunol; 2019 Mar; 31(4):187-198. PubMed ID: 30508092 [TBL] [Abstract][Full Text] [Related]
32. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow. Poh TW; Bradley JM; Mukherjee P; Gendler SJ Cancer Res; 2009 Apr; 69(8):3554-62. PubMed ID: 19351842 [TBL] [Abstract][Full Text] [Related]
33. Immunosuppressive role of CD11b Hyun SY; Na EJ; Jang JE; Chung H; Kim SJ; Kim JS; Kong JH; Shim KY; Lee JI; Min YH; Cheong JW Cancer Med; 2020 Oct; 9(19):7007-7017. PubMed ID: 32780544 [TBL] [Abstract][Full Text] [Related]
34. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function. Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624 [TBL] [Abstract][Full Text] [Related]
35. S100A9 maintains myeloid-derived suppressor cells in chronic sepsis by inducing miR-21 and miR-181b. Alkhateeb T; Kumbhare A; Bah I; Youssef D; Yao ZQ; McCall CE; El Gazzar M Mol Immunol; 2019 Aug; 112():72-81. PubMed ID: 31078118 [TBL] [Abstract][Full Text] [Related]
36. Immunosuppressive CD11b+Ly6Chi monocytes in pristane-induced lupus mouse model. Ma H; Wan S; Xia CQ J Leukoc Biol; 2016 Jun; 99(6):1121-9. PubMed ID: 26657791 [TBL] [Abstract][Full Text] [Related]
37. CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor. Zilio S; Bicciato S; Weed D; Serafini P J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35064009 [TBL] [Abstract][Full Text] [Related]
38. Temporal and spatial profile of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in ischemic stroke in mice. Kawano T; Shimamura M; Nakagami H; Kanki H; Sasaki T; Mochizuki H PLoS One; 2019; 14(5):e0215482. PubMed ID: 31048856 [TBL] [Abstract][Full Text] [Related]
39. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice. Schmid M; Zimara N; Wege AK; Ritter U Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017 [TBL] [Abstract][Full Text] [Related]
40. Premetastatic soil and prevention of breast cancer brain metastasis. Liu Y; Kosaka A; Ikeura M; Kohanbash G; Fellows-Mayle W; Snyder LA; Okada H Neuro Oncol; 2013 Jul; 15(7):891-903. PubMed ID: 23595625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]